Asceneuron raises CHF 30 million in a Series A financing round led by Sofinnova Partners Lausanne, Switzerland, September 29th, 2015. Asceneuron SA, an emerging leader in the development of first-in-class small molecules
Document is deleted from original location. Use the Download Button below to download from the Web Archive.
Asceneuron raises CHF 30 million in a Series A financing round led by Sofinnova Partners Lausanne, Switzerland, September 29th, 2015. Asceneuron SA, an emerging leader in the development of first-in-class small molecules